• Open Access
    Review

    Psychology of bipolar depression: revisiting past and present researches, prospects ahead, and moving toward future directions

    Behrooz Afshari *

    Explor Neurosci. 2023;2:331–349 DOI: https://doi.org/10.37349/en.2023.00032

    Received: June 09, 2023 Accepted: October 11, 2023 Published: December 29, 2023

    Academic Editor: Dirk M. Hermann, University of Duisburg-Essen, Germany

    This article belongs to the special issue Novel Therapeutic Approaches for the Treatment of Depression

    Abstract

    Bipolar disorder (BD) is a debilitating psychiatric disorder characterized by recurrent depression, mania, and hypomania episodes. The interaction of psychological, neuropsychological, and neurobiological factors (cognitive, behavioral, and emotional) is implicated in the development and persistence of BD. Accordingly, almost all investigators confirm that BD is the outcome of psychological and genetic interactions. Therefore, researchers should consider various factors in the psychopathology and psychotherapy of BD. This selective review first reviews research on these factors, then points to a variety of therapeutic methods for BD [interpersonal and social rhythm therapy (IPSRT), cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), mindfulness-based cognitive therapy (MBCT), and family-focused therapy (FFT)], and finally suggested a new comprehensive integrated model for the assessment and therapy of BD.

    Keywords

    Bipolar disorder, psychological factors, comprehensive integrated model

    Introduction

    Nowadays, almost all researchers agree that bipolar disorder (BD) is the result of many genetic and psychological interactions [1]. French psychiatrist Jean-Pierre Falret published an article in 1854 describing what he called “la folie circulaire”, which translated to circular insanity [2]. The article details individuals switching through severe depression and mania and is considered to be the first documented diagnosis of BD [2, 3].

    The definitions and distinctions of BD in the field of mental health are a continuing issue and have been frequently revised by the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD) [4, 5]. The conceptualization of the BD has changed since the first description of mania-depressive illness. Although depression and mania episodes are defined by symptoms that have changed over the years, hypomania episodes have been described with fewer changes and their location is less clear than other episodes. Mania and hypomania episodes are considered dimensional as hypomania is a mild episode of mania [6]. When Dunner [7] and Dunner et al. [8] described BD II, the concept of hypomania was dismissed as a milder form of BD.

    Despite in the past, there are some specific psychological models for BD today. The cognitive model focuses on schemas [9], negative self-thoughts [10], self-concepts [11], and dysfunctional attitudes [12]. The interpersonal model emphasizes marital contrasts, problems at work, transition from adolescence to adulthood, retirement, and on the whole, building and maintaining relationships [11]. The emotional model emphasizes abnormal processing of emotion and poor emotional retention in BD [13]. In this model, emotion is considered as a whole system reaction because it not only includes emotions, memories, and desires but also a way to think [14]. Behavioral activation and behavioral inhibition models are included in the behavioral models of BD, in which behavioral activation is related to the mania episode of BD, and behavioral inhibition is related to the depression episode of BD [15]. Over the past decades, researchers have also pointed to many life events that have been implicated in BD. Symptoms of BD are predictable by emotional expression, self-esteem, social support, cognitive styles, sleep problems, and many other factors [16]. Some other studies have also addressed the psychological aspects of BD such as cognitive vulnerability and coping skills, for example, pathology may be related to the duration of BD and the number of its episodes [17].

    In this selective review, neurobiological, neuropsychological, and psychological models will be referred (behavioral, cognitive, emotional, and personality), then review past and present interventions for BD, and finally, a specific intervention for BD will be addressed that may be useful in improving the efficacy of treatment for the BD and may be an introduction to further researches and design of future therapies.

    BD

    The BD is diagnosed for patients who are experiencing both types of depression and mania episodes or hypomania or who only experience mania episodes. BD I is defined as having at least one mania episode or mixed episodes, and sometimes a major depression episode in the clinical course. The mixed episode is a period of at least one week in which both mania and major depression are found almost daily. A type of BD characterized by major depression and hypomania (and not mania) episodes is called BD II [18]. The ratio of males to females in BD is approximately equal. The combined prevalence of BD I, BD II, and indeterminate BD in the USA in the DSM-5 was estimated at 1.8% and slightly higher (2.7%) in samples of local community youth 12 years and older. The most common disorders associated with BD include alcohol abuse or dependence, panic disorder, obsessive-compulsive disorder, and social anxiety disorder. In BD, men are more likely to present with substance-related disorders and women are more likely to have concurrent anxiety and eating disorders [19].

    Mania episodes are defined by abnormally elevated or irritable mood, accompanied by increased activity, decreased need for sleep, increased self-confidence, flight of ideas, rapid speech, and engagement in pleasurable activities without regard to potential negative consequences [20].

    Over the past decade, many researchers have suggested that BD patients have deficits in brain structures [21], cognitive function [22], executive function [23], emotion regulation [24], and many other factors.

    As mentioned above, a number of theoretical models including cognitive, behavioral, emotional, and interpersonal models have attempted to explain the creation and maintenance of BD. Subsequently, neurobiological, neuropsychological, and psychological models of BD will be examined that attempt to explain this disorder.

    Neurobiological and anatomical models

    Although the diagnosis and treatment of BD are based on psychological and psychiatric models, the neurobiological model has a significant impact on the pathology of this debilitating disorder. The risk of BD in their first-degree relatives is increased [25]. The etiology of BD is not yet clearly defined and involves the interaction between genetic and environmental factors [26]. Also, network connectivity changes may be related to poorer performance in BD patients [21].

    Genetic factors, neurobiological abnormalities, and neurotransmitters play a key role in the etiology of BD. Genome-wide association studies (GWAS) were conducted to determine that genes or genetic factors could play an important role in developing BD. Also, many researchers wanted to investigate genes to find out if these genes make a link with BD [27]. They analyzed genes that were associated with neurophysiological processes which contribute to or are also impaired in BD pathologies. Analyzed genes that play a role in circadian rhythms, dopaminergic and serotonergic pathways, brain development, and neurotropism. Moreover, genes that were associated with schizophrenia were also investigated whether the same genes are associated with BD. Some other studies have supported the presence of noradrenergic system abnormalities in BD [28]. Some research has also supported the important role of the serotonergic system in depression episodes in BD, in that reducing 5-hydroxyindoleacetic has been implicated in impulsivity, aggression, and suicide [27]. Another neurotransmitter that plays an important role in BD is dopamine [28]. The decrease in dopamine has been implicated in depression and its increase in mania and hypomania [29, 30]. Depression episodes in BD are also associated with cholinergic [27].

    Although the mood swing between depression and mania episodes is the most important feature that distinguishes BD from other psychiatric disorders, the neurobiology of the mood swing is still poorly understood [31]. Swings from depression to mania or hypomania can not only occur spontaneously during the course of the illness but also through stress, sleep deprivation, and standard treatment for depression episodes such as electroconvulsive therapy and medication [32, 33]. Several brain regions have also been implicated in the swing from mania to depression, such as the hypothalamic-pituitary-adrenal axis [31].

    Some studies of mental disorders have revealed abnormalities in important parts of the brain such as the frontal cortex [34]. In addition, many patients with frontal lobe injuries have reported deficits in problem-solving and planning their daily activities [35]. Also, there are dysfunctions in the prefrontal cortex and amygdala that are associated with problems in emotion processing [36, 37].

    Another area that has been damaged in BD is the anterior singlet cortex [38]. Deficits in this cortex have been associated with emotional and cognitive dysfunction in BD [39, 40]. Another abnormal region in BD is the orbitofrontal cortex [41]. This cortex plays a role in impulse control and mood regulation [42].

    Neuropsychological factors

    Many studies have pointed to neuropsychological deficits in BD [43]. Studies showed that BD has deficits in attention, executive function, cognitive function, cognitive flexibility, and memory [23]. Xu et al. [22] showed that patients with BD have cognitive dysfunction in processing speed and visual memory, which may be a genetic feature of BD patients. BD is also associated with deficits in executive functions such as cognitive flexibility and attention change [44].

    In BD patients, higher levels of cognitive deficits are associated with frequent hospitalizations, behavioral, emotional, and cognitive responses as well as the inability to delay rewards [45].

    Although the mechanism underlying cognitive deficits in individuals is unclear, many researchers have pointed to the fundamental effects of genes on brain function and cognitive deficits [4648]. These deficits are associated with psychological dysfunctions in areas such as job performance, communication with family members, and life satisfaction. Also, these functions are associated with the severity of symptoms in mental disorders [49].

    Also, numerous executive dysfunctions in BD have been identified, notably that executive deficits have widespread and significant impacts on the lives of bipolar patients, indicating severe problems in controlling and regulating their behaviors [50]. The impact of executive function is so great that researchers refer to it as the basis of almost all of the disorders in the DSM [51]. The neuropsychological structure of executive function and its evaluation methods are different from the neurological disorders present in DSM-5. The major flaw in the diagnostic criteria for neurological disorders present in the DSM-5 is a misunderstanding of clinical neuroscience assessment, especially executive functioning assessment [52]. However, performance-related deficits are associated with the number of mood swings in BD [53]. Some studies showed that the range of cognitive and executive dysfunction in BD patients is related to the course of illness and length of hospitalization, and deficits in the mania episode are more extensive than the other episodes [45].

    Psychological factors

    Psychological factors in BD are very important both clinically and theoretically. Understanding the role of psychological factors in BD can help in understanding the pathology of this disorder and its underlying mechanisms and developing interventions for these patients [54]. Many studies have linked psychological abnormalities associated with depression to unstable self-esteem [55], rumination [56], and distorted attitudes toward self-evaluation [57]. Also, many other studies have linked psychological abnormalities associated with mania to behaviors related to goal achievement and reward [58]. Here research related to behavioral, cognitive, emotional, and personality factors in BD is reviewed.

    Behavioral aspect

    In BD, hypersexuality is also considered a diagnostic criterion [59]. Hypersexuality may be influenced by psychological factors such as psychosocial factors, psychodynamic factors, aggression, and disordered behaviors [60, 61]. Studies show that in bipolar patients who are disturbed in their sexual responses, there is more difficulty in desire, arousal, and the ability to reach orgasm [62].

    During the mania period, patients show impulsive behavior, hyperactivity, thought jumping, and motor hyperactivity, which are considered as an inability to inhibit behavior and thought [63]. These symptoms in BD lead to the destruction of social, occupational, and family functioning [64].

    In children whose parents have BD, the risk of behavioral, emotional, and adjustment problems is higher [65]. Some studies have found that bipolar patients received less warmth and acceptance but more psychological control from their parents in childhood [66].

    Cognitive aspect

    One of the dysfunctional aspects of BD is social cognition. Social cognition is defined as the ability to encode, store, retrieve, and apply social information in a social context [67]. Research shows that cognitive deficits are among the main abnormalities in BD [20].

    Although some studies suggest that cognitive processes affect emotional processes, other studies support that emotional processing affects cognition [20]. Overall, researchers emphasize the mutual influence of cognition and emotion on each other [20]. Some researchers have argued that language processing, processing speed, memory, and attention are related to emotional understanding in BD [68].

    Emotional aspect

    The inability to regulate emotion is one of the first abnormalities of BD, and the two areas that are most important in emotion regulation are the amygdala and the prefrontal cortex [69]. Bipolar patients have problems in emotional processing, emotional perception, emotional learning, emotional memory, and facial expression, which are associated with the dysfunction of the prefrontal cortex and amygdala [36, 37]. Moreover, many studies have suggested that mixed episodes of BD are associated with suicide [70].

    Emotional perception is considered as the first stage of responding to the emotions [67]. Some researchers have reported low accuracy and slow response to emotions such as fear and hatred in BD [71]. Emotional perception ability can predict quality of life in BD [67]. In BD, facial emotion recognition is also related to parenting style [36]. Some research has supported that the deficits in facial emotion recognition may be related to mood state in BD [72]. For example, researchers have found that the ability to recognize negative facial emotion is intact during euthymia while impaired during mania [73]. Research shows that positive or negative effects remain in bipolar patients even after remission [20, 74]. Studies also show that bipolar patients are less able to use emotion regulation strategies but use abnormal strategies instead [75, 76]. Bipolar patients show more problems in controlling speech and behavior than healthy people [77].

    Some studies have supported that emotion dysregulation is observed early in BD in patients [78]. Some other studies show that negative emotion regulation is related to the severity of depression symptoms [79, 80]. Emotions related to impulsivity in BD are also related to aggression and suicide [81]. Also, the ability to regulate positive and negative emotions has an important impact on the consequences of BD [20].

    Most research shows that BD is more related to negative emotions and maybe less related to positive emotions [20]. These patients are less confident in using emotion regulation strategies. Also, emotional variables have prominent effects on the consequences of BD. Incorrect and negative emotion regulation strategies are related to dysfunction in BD [20].

    High levels of emotion may also be involved in executive functioning [82]. In fact, better skills in regulating emotions have a great impact on improving executive functioning [83], especially working memory [84], cognitive flexibility [85], and cognitive inhibition [86].

    Personality aspect

    Personality has been implicated in the etiology, development, and continuation of BD. Kraepelin [87] suggested that there are several specific temperaments in mania-depressive disorder. The most important of which can be the moody “depressive” temperament, the impulsive “mania” temperament, and the hot-tempered “irritable” temperament. Then, many studies have examined personality in BD [88, 89].

    Recent investigations have assessed the relevance of various theories of personality for BD [88]. For example, psychosocial personality dimensions, such as extraversion, inhibition, and impulsivity, are higher in BD patients than in normal individuals [89]. Also, Cloninger’s personality theory has been used for mood disorders, and in BD, higher scores have been reported for novelty seeking, reward dependence, and self-transcendence [90].

    More studies have been conducted on the behavior activation system in BD [88] with the general finding that activity in this system is significantly stronger than in normal people. Also, it has been reported that BD patients expend more effort when striving towards their goals, further supporting the role of the behavior activation system [89]. In addition, the higher levels of behavior activation system activity in BD patients are associated with high rates of behavioral and cognitive responses, as well as a weakened inability to postpone rewards [15]. Also, Meyer et al. [91] showed that behavior activation system scores related to mania and behavior inhibition system scores are related to depression. Also, an increasing behavior activation system in BD is consistent with increased dopamine levels and more dopaminergic activity [92]. The behavior activation system is controlled by the dopaminergic route as well as the limbic system and its components such as the amygdala [93]. Individuals with strong behavioral activation systems are reward-sensitive, are more likely to use high-risk behaviors, and show more impulsive behaviors [15].

    Bipolar patients have higher scores on neuroticism, extraversion, and disinhibition than healthy individuals. Neuroticism predicts depression episodes and suicidal behaviors [94].

    Barnet et al. [95] found that increasing neuroticism along with a decrease in extraversion may indicate a person prone to depression, while not predicting a specific characteristic of a mania episode. Overall, many studies have investigated the personality traits of BD and have shown that these patients have many differences from healthy individuals.

    Revisiting past and present interventions for BD

    Over the past few decades, many preventive interventions have been suggested for BD. BD is a debilitating and costly condition, and for this reason, special treatments are now available for it [96]. The main treatment for BD is medication, and a few researches have been done on the psychotherapy of these patients, of which much less have been approved [54, 83].

    Medication

    Medication is the cornerstone and the main treatment for BD. Although success has been achieved in the treatment of BD [97], this treatment alone is not effective and is associated with approximately 40–60% recurrence [98]. Also, none of the mood stabilizers have had a significant effect on the treatment of BD [99]. The therapeutic response of BD patients to medication is only 50% [97]. However, mood stabilizers can lead to problems such as metabolic and cardiovascular diseases. In addition, 50% of BD patients have at least one non-adherence to medication [100]. In BD, polypharmacy is a rule, not an exception [98]. Finally, it is better to point out that medication alone cannot improve cognitive deficits such as memory as well as executive deficits such as problem-solving [17].

    Cognitive behavioral therapy

    One of the psychotherapies used for BD is cognitive behavioral therapy (CBT). This treatment deals with the cognitive and behavioral patterns of BD [101]. In several randomized controlled trials (RCTs), CBT has been shown to decrease the severity of depression and improve some of the functions of BD [102], but CBT may be less effective with high severity of BD or those with multiple episodes. Some findings indicate that CBT is an effective treatment for depression episodes in BD, but its effectiveness for mania episodes is questionable [98]. Also, Scott [101] showed that CBT may be more useful for BD patients who are in the early stages of their disorder (see Table 1 for more information) [103119].

    CBT for BD

    StudyMean ageSample sizeFemaleIntervention typeOutcomesFollow-up
    Nielssen et al. [103]44835510 weekly group sessionsReductions in symptoms of depression and mania6 months
    Henken et al. [104]46231810 weekly group sessionsVariation in mood states diminished; there was a change from depressive states to more euthymic states; there was an increase in overall psychosocial functioning and self-reported psychological health2 months and 12 months
    Weinstein et al. [105]9.19692912 weekly group child- and family-focused CBTHigher self-esteem; decreases in depression and mania symptoms, suicidal ideation, and anxiety; improving mental health in children and parents6 months
    Steinan et al. [106]32.440248 weekly individual sessionsImprovement in sleep quality; lower scores in mania and depression6 months
    West et al. [107]9.15692812 weekly group child- and family-focused CBTReducing mania and depression symptoms; improvement in global functioning6 months
    Costa et al. [108]41.5412714 weekly group sessionsLower scores for mania (not statistically significant) and depression (statistically significant) as well as a reduction in the frequency and duration of mood episodes; significant improvement in mental health6 months
    González-Isasi et al. [109]41.30401920 weekly individual sessionsFewer hospitalizations corresponded to better progression, and higher self-esteem corresponded to better prognosis6 months and 12 months
    Parikh and Scott [110]40.920411820 weekly individual sessionsSignificantly lower scores in mania and depression18 months
    Gomes et al. [111]38.5502718 weekly group sessionsSignificant decreases in the number of depression and mania episodes, and managing mania symptoms12 months
    da Costa et al. [112]40.5372514 weekly group sessionsFewer symptoms of mania, depression, and anxiety, as well as fewer and shorter mood change episodes6 months
    West et al. [113]9.45261112 weekly group child- and family-focused CBTSignificant improvement in mania symptoms; parents reported an increased ability to cope with their child’s illnessNone
    Zaretsky et al. [114]40.7794614 weekly individual sessionsLower levels of affective symptoms and higher psychosocial functioning; fifty percent fewer days of depressed mood over the course of one year12 months
    Reilly-Harrington et al. [115]38.410620 weekly individual sessionsSignificant decreases in depressive mood; decreases in mania; significant decreases in anxiety2 months
    Scott et al. [116]4125313022 weekly individual sessionsSignificant decreases in depression, mania, and hypomania6 months, 12 months, and 18 months
    Feeny et al. [117]1416912 weekly individual sessionsSignificantly lower scores in depression and mania2 months
    Pavuluri et al. [118]11.33341012 weekly group child- and family-focused CBTSignificant reductions in ADHD, depression, mania, psychosis, aggression, and sleep disturbance; high levels of treatment integrity, adherence, and satisfactionNone
    Patelis-Siotis et al. [119]39.8492814 weekly group sessionsLower scores in symptom severity, and significant improvement in mental healthNone
    Display full size

    ADHD: attention deficit/hyperactivity disorder

    Interpersonal and social rhythm therapy

    Interpersonal and social rhythm therapy (IPSRT) is a psychotherapy specifically designed for BD and includes two sections of social rhythm therapy and interpersonal psychotherapy [118]. Other studies showed that IPSRT may reduce the severity of depression in BD [120]. Swartz et al. [121] have shown that IPSRT may be an effective treatment for depression episodes of BD. They also showed that IPSRT helps to reduce depression episodes of BD better than medication. Furthermore, it was reported that IPSRT improved mood disorders (see Table 2 for more information) [122127].

    IPSRT for BD

    StudyMean ageSample sizeFemaleIntervention typeOutcomesFollow-up
    Steardo et al. [122]49.1221412 weekly individual sessionsImprovement in anxious, depressive, mania symptomatology, and global functioning3 months and 6 months
    Frank et al. [123]24.3342212 weekly individual sessionsDecreases in mood symptoms and improvement in psychological functioning6 months
    Goldstein et al. [52]15.213612 weekly individual sessionsDecreases in mood symptoms and improvement in psychological functioning6 months
    Bouwkamp et al. [124]41.4221024 weekly group sessionsDecreases in depressive symptoms and number of hospital admissions; increased stability of the social rhythmNone
    Hlastala et al. [125]16.512618 weekly individual sessionsSignificant decreases in mania, depressive, and general psychiatric symptoms; increased global functioning12 months
    Frank et al. [126]34.51257424 weekly group sessionsMore rapid improvement in occupational functioningNone
    Orhan et al. [127]341759212 weekly individual sessionsAbility to increase regularity of social rhythm; significant decreases in symptom severity24 months
    Display full size

    Dialectical behavior therapy

    Another type of psychotherapy for BD is dialectical behavior therapy (DBT). DBT developed by Linehan et al. [128] is a type of psychotherapy initially used to treat patients with borderline personality disorder, suicidal behaviors, and self-harm. This method was later used to treat other mental disorders such as BD [128]. The effectiveness of DBT in reducing depression severity, emotion regulation, and suicide reduction suggests that DBT can be effective in the treatment of BD [98]. DBT has been found to be effective in reducing suicidal behaviors, emotion dysregulation, and depression severity in BD [129131]. Effective in impaired dysfunction, Steardo et al. [122], showed that DBT for 12 months resulted in decreased amygdala activity and improved mood and emotion regulation in patients with BD. They also showed that DBT intervention for 3 months decreased amygdala activity and improved emotion regulation (see Table 3 for more information) [122, 130, 132, 133].

    DBT for BD

    StudyMean ageSample sizeFemaleIntervention typeOutcomesFollow-up
    Samadi et al. [131]16.240208 weekly group sessionsReduces aggression, self-criticism, and self-injurious behaviorsNone
    Afshari et al. [132]36.5603412 weekly individual sessionsLower scores in mania, depression, and emotion dysregulation; higher scores in mindfulness, planning, problem-solving, and cognitive flexibility3 months
    Eisner et al. [133]41.3372712-week DBT group skills trainingSkill acquisition in the areas of mindfulness, emotion regulation, and distress tolerance; improved psychological well-being and decreased emotion reactivity6 months
    Goldstein et al. [130]16.3201536 weekly individual sessionsAcceptability of the intervention was high, with less severe depressive symptoms and suicidal ideation, a significant improvement from pre- to post-treatment in mania symptoms, and emotional dysregulation12 months
    Van Dijk et al. [98]43.2241812 weekly group sessionsA trend toward reduced depressive symptoms, significant improvement in mindful awareness, and less fear toward and more control of emotional states; group attendees had reduced emergency room visits and mental health related admissions in the six-month follow-up6 months
    Display full size

    Family-focused therapy

    Family-focused therapy (FFT) has also been shown to be effective in treating BD. The FFT was initially formulated for families of people at risk for schizophrenia and targeted high levels of emotion. FFT was then adapted to treat BD [118]. Several studies have shown that FFT significantly reduces the duration of depression in BD [134, 135]. The FFT can also be effective in reducing the rates of depression in adolescents. Researchers have hypothesized that the effects of FFT on BD may be due to family support for patients. It can also be effective in reducing family problems and poor social functioning (see Table 4 for more information) [105, 118, 136142].

    FFT for BD

    StudyMean ageSample sizeFemaleIntervention typeOutcomesFollow-up
    Tabas et al. [136]31.88601612 weekly group sessionsImproved relapse prevention and promoted social functioning3 months
    Fredman et al. [137]35.611086721 weekly individual sessionsImprovements in mania symptoms; showing appropriate self-sacrificeNone
    West et al. [107]9.15692812 weekly group child- and family-focused CBTReducing mania and depression symptoms; improvement in global functioning6 months
    Miklowitz and Chung [138]14.4523321 weekly individual sessionsReductions in depressive and mania symptoms12 months
    Solomon et al. [139]41533012 weekly individual sessionsRecovering from mood episodes; changing attitude toward the illness; decreasing feelings of isolation and burden; significantly fewer hospitalizations; increasing the ability to manage symptoms and mood episodes6 months
    Miller [140]39925212 weekly group sessionsSignificantly improves recovery from BD I mood episodesNone
    Reinares et al. [141]35.4452212 weekly group sessionsIncreasing caregivers’ knowledge of BD, reduced caregivers’ belief about the link between disruption in life and the patient’s behavior, and reduced the caregivers’ subjective burden3 months
    Weisman et al. [142]27.19262621 weekly individual sessionsDecreases in hospitalization; improvement in problem-solving and management of episodes24 months
    Display full size

    Mindfulness-based cognitive therapy

    Mindfulness-based cognitive therapy (MBCT) is a treatment protocol that includes meditation practices and CBT exercises. This treatment, which was formulated for unipolar depression [143], was later adapted for depression episodes in BD [118]. Some studies have reported positive results of using MBCT for BD I and BD II [144]. The MBCT helps patients to be more able to observe their thoughts and feelings and to experience less depression [144146]. A study of the use of MBCT for BD showed a significant reduction in anxiety in BD patients [147]. MBCT may also be effective in treating cognitive and emotional problems associated with depression episodes of BD and reduce residual symptoms of BD (see Table 5 for more information) [118, 148156].

    MBCT for BD

    StudyMean ageSample sizeFemaleIntervention typeOutcomesFollow-up
    Hanssen et al. [150]46.672438 weekly group sessionsReducing current depressive symptoms; improving mindfulness skills; reducing trait anxiety; positive mental health15 months
    Weber et al. [151]48715312 weekly group sessionsDecreases in depression and anxiety symptoms; improving quality of life, attention, emotion regulation abilities, psychological well-being, psychological functioning, and self-efficacy; greater self-awareness3 months
    Miklowitz et al. [152]33.739398 weekly group sessionsIncreasing mindfulness and improvements in depression6 months
    Lahera et al. [153]41140868 weekly group sessionsReduced depressive symptoms and improved cognitive performance3 months
    Howells et al. [154]3712108 weekly group sessionsImproved attention readiness; attenuated activation of non-relevant information processing during the attention processNone
    Stange et al. [155]428612 weekly group sessionsImproving mindfulness, nonjudgmental observance and awareness of thoughts, feelings, sensations, and executive functioning24 months
    Weber et al. [156]4815118 weekly group sessionsImproving mindfulness and decreasing depression12 months
    Display full size

    Although each therapeutic pattern used for BD is based on a specific theoretical orientation, there are several aspects in common. First, each of these therapies targets specific symptoms and has a limited effect on BD, for example, CBT is effective in reducing the severity of depression but does not work for mania. Second, these therapies (except IPSRT) are not initially designed to treat BD. Taken together, these findings suggest that current interventions for BD (both medication and psychotherapy) need to be improved and promote their effectiveness in BD. Therefore, it is imperative to seek more effective treatments that address BD and target the symptoms directly.

    Integrated model for bipolar depression

    Psychopathology

    As mentioned earlier, in the psychopathology field of BD, it is better to pay attention to behavioral, cognitive, emotional, personality, and neuropsychological factors. In this case, a more comprehensive understanding of BD will be obtained, although this may be relatively time-consuming. Psychopathology is the introduction to the treatment of BD. Therefore, the primary focus should be on the correct recognition of all factors that cause and maintain BD.

    Assessment

    The first stage will be an interview with bipolar patients so that after the diagnosis of BD is confirmed, the symptoms of the disorder and their severity, the patient’s performance (cognitive, executive, and emotional functions), quality of life, coping abilities, and the patient’s weaknesses and strengths are identified. It is better to design a tool to measure all functions together. The proposed tool can combine several questionnaires and neuropsychological tests and examine cognitive, executive, emotional, personality, and neuropsychological functions comprehensively. Considering the scope of the evaluation, it is better to evaluate the clients in several sessions (two or three sessions). Then all the functions of the clients are given a score and all the scores are compared in a graph to determine what the best and worst functions of the clients are. It is suggested that the evaluation be done in three stages: before the treatment, in the middle of the treatment, and after the end of the treatment (Figure 1).

    The proposed assessment module for BD

    Intervention

    Considering the past and present efforts regarding psychotherapy for bipolar depression, designing a separate treatment for this disorder will bring new perspectives to researchers and therapists. With the help of previous theories about BD, designing a special treatment for BD, directly targets the problems of these patients, and takes steps to reduce the pain caused by this abnormality.

    After patients have been comprehensively evaluated, functions improvement therapy can be used. This treatment covers all the functions and symptoms as well as the weak and strong points of the person. The treatment plan is based on the problems identified in the assessment phase. It is better to have short-term treatment in weekly sessions. In all stages, treatment is carried out individually. In each session, the materials of the previous session are reviewed and a review of assignments is also done.

    Treatment should teach patients skills to manage their disorder. Treatment should cover both the depressive and mania phases. It is better for researchers and therapists, regardless of their theoretical approach, to evaluate this special type of treatment for BD so that the effectiveness of this treatment can be investigated in numerous studies. It is better to evaluate the effectiveness of this treatment compared to other treatments such as CBT and DBT. It is an eclectic therapy that uses techniques from other therapies in a framework that best fits BD.

    Conclusion

    According to the passage, the interaction of neurobiological, neuropsychological, and psychological factors (behavioral, cognitive, emotional, and personality) is involved in the development and persistence of BD. Indeed, nowadays, almost all researchers agree that BD is the result of many genetic and psychological interactions. Hence, investigators should consider various factors in the psychopathology and psychotherapy of BD. This selective review first reviewed research on these factors, then pointed to a variety of treatment models for BD (CBT, IPSRT, DBT, FFT, and MBCT), and finally proposed a new comprehensive integrated model for the evaluation and treatment of BD.

    Abbreviations

    BD:

    bipolar disorder

    CBT:

    cognitive behavioral therapy

    DBT:

    dialectical behavior therapy

    DSM:

    Diagnostic and Statistical Manual of Mental Disorders

    FFT:

    family-focused therapy

    IPSRT:

    interpersonal and social rhythm therapy

    MBCT:

    mindfulness-based cognitive therapy

    Declarations

    Acknowledgments

    I would like to thank my colleagues and friends at “Amir Kabir Rehabilitation Center for the Disabled’’ in Kashan as well as “Social Welfare Department of the city of Kashan’’ for their intellectual assistance and thoughtful insights on an earlier draft of this paper.

    Author contributions

    BA: Conceptualization, Investigation, Methodology, Project administration, Writing—original draft, Writing—review & editing.

    Conflicts of interest

    The author declares that he has no conflicts of interest.

    Ethical approval

    Not applicable.

    Consent to participate

    Not applicable.

    Consent to publication

    Not applicable.

    Availability of data and materials

    Not applicable.

    Funding

    Not applicable.

    Copyright

    © The Author(s) 2023.

    References

    Thesing CS, Stek ML, van Grootheest DS, van de Ven PM, Beekman AT, Kupka RW, et al. Childhood abuse, family history and stressors in older patients with bipolar disorder in relation to age at onset. J Affect Disord. 2015;184:24955. [DOI] [PubMed]
    Sedler MJ. Falret’s discovery: the origin of the concept of bipolar affective illness. Am J Psychiatry. 1983;140:112733. [DOI] [PubMed]
    Falret JP. Mémoire sur la folie circulaire. Bull Acad Natl Med. 1854;19:382415. French.
    Fletcher K, Tan EJ, Scott J, Murray G. Bipolar II disorder: the need for clearer definition and improved management. Aust N Z J Psychiatry. 2018;52:5989. [DOI] [PubMed]
    Malhi GS, Hamilton A, Morris G, Irwin L. No bipolar II–for me, or for you! Aust N Z J Psychiatry. 2018;52:599601. [DOI] [PubMed]
    Parker G, Tavella G, Macqueen G, Berk M, Grunze H, Deckersbach T, et al. Revising diagnostic and statistical manual of mental disorders, fifth edition, criteria for the bipolar disorders: phase I of the AREDOC project. Aust N Z J Psychiatry. 2018;52:117382. [DOI] [PubMed]
    Dunner DL. Bipolar II disorder. Bipolar Disord. 2017;19:5201. [DOI] [PubMed]
    Dunner DL, Gershon ES, Goodwin FK. Heritable factors in the severity of affective illness. Biol Psychiatry. 1976;11:3142. [PubMed]
    Newman CF, Leahy RL, Beck AT, Reilly-Harrington NA, Gyulai L. Bipolar disorder: a cognitive therapy approach. American Psychological Association; 2002.
    Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York: The Guilford Press; 1979.
    Power MJ. Psychological approaches to bipolar disorders: a theoretical critique. Clin Psychol Rev. 2005;25:110122. [DOI] [PubMed]
    Lam D, Wright K, Smith N. Dysfunctional assumptions in bipolar disorder. J Affect Disord. 2004;79:1939. [DOI] [PubMed]
    Green MJ, Cahill CM, Malhi GS. The cognitive and neurophysiological basis of emotion dysregulation in bipolar disorder. J Affect Disord. 2007;103:2942. [DOI] [PubMed]
    Sheri Van Dijk MSW. DBT made simple: a step-by-step guide to dialectical behavior therapy. New Harbinger Publications; 2013.
    Afshari B, Rasouli-Azad M, Ghoreishi FS. Comparison of original and revised reinforcement sensitivity theory in clinically-stable schizophrenia and bipolar disorder patients. Pers Individ Dif. 2019;138:3217. [DOI]
    Johnson SL. Life events in bipolar disorder: towards more specific models. Clin Psychol Rev. 2005;25:100827. [DOI] [PubMed] [PMC]
    Scott J, Stanton B, Garland A, Ferrier IN. Cognitive vulnerability in patients with bipolar disorder. Psychol Med. 2000;30:46772. [DOI] [PubMed]
    Sadock BJ, Sadock VA. Kaplan and Sadock’s synopsis of psychiatry: behavioral sciences/clinical psychiatry. 10th ed. Lippincott Williams & Wilkins; 2011.
    American Psychiatric Association; DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5TM, 5th ed. Washington, DC: American Psychiatric Association; 2013.
    Lima IMM, Peckham AD, Johnson SL. Cognitive deficits in bipolar disorders: implications for emotion. Clin Psychol Rev. 2018;59:12636. [DOI] [PubMed] [PMC]
    Schneider MR, DelBello MP, McNamara RK, Strakowski SM, Adler CM. Neuroprogression in bipolar disorder. Bipolar Disord. 2012;14:35674. [DOI] [PubMed]
    Xu G, Lin K, Rao D, Dang Y, Ouyang H, Guo Y, et al. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study. J Affect Disord. 2012;136:32839. [DOI] [PubMed]
    Krabbendam L, Arts B, van Os J, Aleman A. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res. 2005;80:13749. [DOI] [PubMed]
    Cipollone G, Paolilli FL, Novi M, Masci I, Caruso D, MorettoUet al. 0959 Evening chronotypes mediate the association between early life stress and emotion dysregulation in bipolar disorder: a pilot study. Sleep. 2018;41:A356. [DOI]
    Harrison PJ, Geddes JR, Tunbridge EM. The emerging neurobiology of bipolar disorder. Trends Neurosci. 2018;41:1830. [DOI] [PubMed] [PMC]
    Maruani J, Anderson G, Etain B, Lejoyeux M, Bellivier F, Geoffroy PA. The neurobiology of adaptation to seasons: relevance and correlations in bipolar disorders. Chronobiol Int. 2018;35:133553. [DOI] [PubMed]
    Manji HK, Quiroz JA, Payne JL, Singh J, Lopes BP, Viegas JS, et al. The underlying neurobiology of bipolar disorder. World Psychiatry. 2003;2:13646. [PubMed] [PMC]
    Shiah IS, Yatham LN. Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies. Bipolar Disord. 2000;2:7792. [DOI] [PubMed]
    Willner P, Muscat R, Phillips G. The role of dopamine in rewarded behavior: ability, insight, drive or incentive? Pol J Pharmacol Pharm. 1991;43:291300. [PubMed]
    Maes M, Meltzer HY, D’Hondt P, Cosyns P, Blockx P. Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Psychoneuroendocrinology. 1995;20:14967. [DOI] [PubMed]
    Salvadore G, Quiroz JA, Machado-Vieira R, Henter ID, Manji HK, Zarate CA Jr. The neurobiology of the switch process in bipolar disorder: a review. J Clin Psychiatry. 2010;71:1488501. [DOI] [PubMed] [PMC]
    Grunze HC. Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation? CNS Spectr. 2008;13:7905. [DOI] [PubMed]
    Licht RW, Gijsman H, Nolen WA, Angst J. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration. Acta Psychiatr Scand. 2008;118:33746. [DOI] [PubMed]
    Marvel CL, Paradiso S. Cognitive and neurological impairment in mood disorders. Psychiatr Clin North Am. 2004;27:1936. [DOI] [PubMed] [PMC]
    Unterrainer JM, Owen AM. Planning and problem solving: from neuropsychology to functional neuroimaging. J Physiol Paris. 2006;99:30817. [DOI] [PubMed]
    Rich BA, Fromm SJ, Berghorst LH, Dickstein DP, Brotman MA, Pine DS, et al. Neural connectivity in children with bipolar disorder: impairment in the face emotion processing circuit. J Child Psychol Psychiatry. 2008;49:8896. [DOI] [PubMed] [PMC]
    Pavuluri MN, Passarotti AM, Harral EM, Sweeney JA. An fMRI study of the neural correlates of incidental versus directed emotion processing in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2009;48:30819. [DOI] [PubMed] [PMC]
    Fornito A, Malhi GS, Lagopoulos J, Ivanovski B, Wood SJ, Saling MM, et al. Anatomical abnormalities of the anterior cingulate and paracingulate cortex in patients with bipolar I disorder. Psychiatry Res. 2008;162:12332. [DOI] [PubMed]
    Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol Psychiatry. 2003;54:50414. [DOI] [PubMed]
    Ridderinkhof KR, Ullsperger M, Crone EA, Nieuwenhuis S. The role of the medial frontal cortex in cognitive control. Science. 2004;306:4437. [DOI] [PubMed]
    Najt P, Nicoletti M, Chen HH, Hatch JP, Caetano SC, Sassi RB, et al. Anatomical measurements of the orbitofrontal cortex in child and adolescent patients with bipolar disorder. Neurosci Lett. 2007;413:1836. [DOI] [PubMed] [PMC]
    Price JL. Prefrontal cortical networks related to visceral function and mood. Ann N Y Acad Sci. 1999;877:38396. [DOI] [PubMed]
    Afshari B, Khezrian K, Faghihi A. Examination and comparison of cognitive and executive functions in patients with schizophrenia and bipolar disorders. J Isfahan Med Sch. 2019;37:2707. [DOI] [PubMed] [PMC]
    Tian F, Diao W, Yang X, Wang X, Roberts N, Feng C, et al. Failure of activation of striatum during the performance of executive function tasks in adult patients with bipolar disorder. Psychol Med. 2020;50:65365. [DOI] [PubMed]
    Dixon T, Kravariti E, Frith C, Murray RM, McGuire PK. Effect of symptoms on executive function in bipolar illness. Psychol Med. 2004;34:81121. [DOI] [PubMed]
    Butcher LM, Davis OS, Craig IW, Plomin R. Genome-wide quantitative trait locus association scan of general cognitive ability using pooled DNA and 500K single nucleotide polymorphism microarrays. Genes Brain Behav. 2008;7:43546. [DOI] [PubMed] [PMC]
    Knöchel C, Stäblein M, Prvulovic D, Ghinea D, Wenzler S, Pantel J, et al. Shared and distinct gray matter abnormalities in schizophrenia, schizophrenia relatives and bipolar disorder in association with cognitive impairment. Schizophr Res. 2016;171:1408. [DOI] [PubMed]
    Le Hellard S, Håvik B, Espeseth T, Breilid H, Løvlie R, Luciano M, et al. Variants in doublecortin- and calmodulin kinase like 1, a gene up-regulated by BDNF, are associated with memory and general cognitive abilities. PLoS One. 2009;4:e7534. [DOI] [PubMed] [PMC]
    Rajji TK, Miranda D, Mulsant BH. Cognition, function, and disability in patients with schizophrenia: a review of longitudinal studies. Can J Psychiatry. 2014;59:137. [DOI] [PubMed] [PMC]
    Dickinson T, Becerra R, Coombes J. Executive functioning deficits among adults with bipolar disorder (types I and II): a systematic review and meta-analysis. J Affect Disord. 2017;218:40727. [DOI] [PubMed]
    McCloskey G, Perkins LA, Van Diviner B. Executive function development and related issues. In: Assessment and intervention for executive function difficulties. New York: Taylor & Francis Group; 2008. pp. 65–89.
    Goldstein S, Naglieri JA, Princiotta D, Otero TM. Introduction: a history of executive functioning as a theoretical and clinical construct. In: Goldstein S, Naglieri J, editors. Handbook of executive functioning. New York: Springer; 2014. pp. 3–12.
    Yang T, Zhao G, Mao R, Huang J, Xu X, Su Y, et al. The association of duration and severity of disease with executive function: differences between drug-naïve patients with bipolar and unipolar depression. J Affect Disord. 2018;238:4127. [DOI] [PubMed]
    Van der Gucht E, Morriss R, Lancaster G, Kinderman P, Bentall RP. Psychological processes in bipolar affective disorder: negative cognitive style and reward processing. Br J Psychiatry. 2009;194:14651. [DOI] [PubMed]
    Knowles R, Tai S, Jones SH, Highfield J, Morriss R, Bentall RP. Stability of self-esteem in bipolar disorder: comparisons among remitted bipolar patients, remitted unipolar patients and healthy controls. Bipolar Disord. 2007;9:4905. [DOI] [PubMed]
    Thomas J, Knowles R, Tai S, Bentall RP. Response styles to depressed mood in bipolar affective disorder. J Affect Disord. 2007;100:24952. [DOI] [PubMed]
    Scott J, Pope M. Cognitive styles in individuals with bipolar disorders. Psychol Med. 2003;33:10818. [DOI] [PubMed]
    Johnson SL, Sandrow D, Meyer B, Winters R, Miller I, Solomon D, et al. Increases in manic symptoms after life events involving goal attainment. J Abnorm Psychol. 2000;109:7217. [DOI] [PubMed] [PMC]
    Mazza M, Harnic D, Catalano V, Di Nicola M, Bruschi A, Bria P, et al. Sexual behavior in women with bipolar disorder. J Affect Disord. 2011;131:3647. [DOI] [PubMed]
    Adelson S. Psychodynamics of hypersexuality in children and adolescents with bipolar disorder. J Am Acad Psychoanal Dyn Psychiatry. 2010;38:2745. [DOI] [PubMed]
    Bakare MO, Agomoh AO, Ebigbo PO, Onyeama GM, Eaton J, Onwukwe JU, et al. Co-morbid disorders and sexual risk behavior in Nigerian adolescents with bipolar disorder. Int Arch Med. 2009;2:16. [DOI] [PubMed] [PMC]
    Dell’Osso L, Carmassi C, Carlini M, Rucci P, Torri P, Cesari D, et al. Sexual dysfunctions and suicidality in patients with bipolar disorder and unipolar depression. J Sex Med. 2009;6:306370. [DOI] [PubMed]
    Young JW, Minassian A, Paulus MP, Geyer MA, Perry W. A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neurosci Biobehav Rev. 2007;31:88296. [DOI] [PubMed] [PMC]
    Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry. 2003;64:68090. [DOI] [PubMed]
    Calam R, Jones S, Sanders MR, Dempsey R, Sadhnani V. Parenting and the emotional and behavioural adjustment of young children in families with a parent with bipolar disorder. Behav Cogn Psychother. 2012;40:42537. [DOI] [PubMed]
    Neeren AM, Alloy LB, Abramson LY. History of parenting and bipolar spectrum disorders. J Soc Clin Psychol. 2008;27:102144. [DOI]
    Fulford D, Peckham AD, Johnson K, Johnson SL. Emotion perception and quality of life in bipolar I disorder. J Affect Disord. 2014;152–154:4917. [DOI] [PubMed] [PMC]
    Van Rheenen TE, Rossell SL. Objective and subjective psychosocial functioning in bipolar disorder: an investigation of the relative importance of neurocognition, social cognition and emotion regulation. J Affect Disord. 2014;162:13441. [DOI] [PubMed]
    Townsend J, Altshuler LL. Emotion processing and regulation in bipolar disorder: a review. Bipolar Disord. 2012;14:32639. [DOI] [PubMed]
    McElroy SL, Kotwal R, Kaneria R, Keck PE Jr. Antidepressants and suicidal behavior in bipolar disorder. Bipolar Disord. 2006;8:596617. [DOI] [PubMed]
    Yurgelun-Todd DA, Gruber SA, Kanayama G, Killgore WD, Baird AA, Young AD. fMRI during affect discrimination in bipolar affective disorder. Bipolar Disord. 2000;2:23748. [DOI] [PubMed]
    Niedenthal PM, Halberstadt JB, Margolin J, Innes‐Ker ÅH. Emotional state and the detection of change in facial expression of emotion. Eur J Soc Psychol. 2000;30:21122. [DOI]
    Lembke A, Ketter TA. Impaired recognition of facial emotion in mania. Am J Psychiatry. 2002;159:3024. [DOI] [PubMed]
    Gruber J, Harvey AG, Johnson SL. Reflective and ruminative processing of positive emotional memories in bipolar disorder and healthy controls. Behav Res Ther. 2009;47:697704. [DOI] [PubMed] [PMC]
    Gruber J, Dutra S, Eidelman P, Johnson SL, Harvey AG. Emotional and physiological responses to normative and idiographic positive stimuli in bipolar disorder. J Affect Disord. 2011;133:43742. [DOI] [PubMed] [PMC]
    Gruber J, Harvey AG, Gross JJ. When trying is not enough: emotion regulation and the effort-success gap in bipolar disorder. Emotion. 2012;12:9971003. [DOI] [PubMed]
    Muhtadie L, Johnson SL, Carver CS, Gotlib IH, Ketter TA. A profile approach to impulsivity in bipolar disorder: the key role of strong emotions. Acta Psychiatr Scand. 2014;129:1008. [DOI] [PubMed] [PMC]
    Chang KD, Blasey CM, Ketter TA, Steiner H. Temperament characteristics of child and adolescent bipolar offspring. J Affect Disord. 2003;77:119. [DOI] [PubMed]
    Gilbert KE, Nolen-Hoeksema S, Gruber J. Positive emotion dysregulation across mood disorders: How amplifying versus dampening predicts emotional reactivity and illness course. Behav Res Ther. 2013;51:73641. [DOI] [PubMed]
    Green MJ, Lino BJ, Hwang EJ, Sparks A, James C, Mitchell PB. Cognitive regulation of emotion in bipolar I disorder and unaffected biological relatives. Acta Psychiatr Scand. 2011;124:30716. [DOI] [PubMed]
    Johnson SL, Carver CS. Emotion-relevant impulsivity predicts sustained anger and aggression after remission in bipolar I disorder. J Affect Disord. 2016;189:16975. [DOI] [PubMed]
    Pessoa L. How do emotion and motivation direct executive control? Trends Cogn Sci. 2009;13:1606. [DOI] [PubMed] [PMC]
    von Hippel W, Gonsalkorale K. “That is bloody revolting!” Inhibitory control of thoughts better left unsaid. Psychol Sci. 2005;16:497500. [DOI] [PubMed]
    Hendricks MA, Buchanan TW. Individual differences in cognitive control processes and their relationship to emotion regulation. Cogn Emot. 2016;30:91224. [DOI] [PubMed]
    Malooly AM, Genet JJ, Siemer M. Individual differences in reappraisal effectiveness: the role of affective flexibility. Emotion. 2013;13:30213. [DOI] [PubMed]
    Joormann J, Vanderlind WM. Emotion regulation in depression: the role of biased cognition and reduced cognitive control. Clin Psychol Sci. 2014;2:40221. [DOI]
    Kraepelin E. Manic-depressive insanity and paranoia. Edinburgh: E. & S. Livingstone; 1921.
    Qiu F, Akiskal HS, Kelsoe JR, Greenwood TA. Factor analysis of temperament and personality traits in bipolar patients: correlates with comorbidity and disorder severity. J Affect Disord. 2017;207:28290. [DOI] [PubMed] [PMC]
    Sparding T, Pålsson E, Joas E, Hansen S, Landén M. Personality traits in bipolar disorder and influence on outcome. BMC Psychiatry. 2017;17:159. [DOI] [PubMed] [PMC]
    Hajirezaei S, Mohammadi A, Soleimani M, Rahiminezhad F, Mohammadi MR, Cloninger CR. Comparing the profile of temperament and character dimensions in patients with major depressive disorder and bipolar mood disorder with a control group. Iran J Psychiatry. 2017;12:14753. [PubMed] [PMC]
    Meyer B, Johnson SL, Winters R. Responsiveness to threat and incentive in bipolar disorder: relations of the BIS/BAS scales with symptoms. J Psychopathol Behav Assess. 2001;23:13343. [DOI] [PubMed] [PMC]
    Aguilar DD, Giuffrida A, Lodge DJ. Adolescent synthetic cannabinoid exposure produces enduring changes in dopamine neuron activity in a rodent model of schizophrenia susceptibility. Int J Neuropsychopharmacol. 2018;21:393403. [DOI] [PubMed] [PMC]
    Pickering AD, Smillie LD. The behavioural activation system: challenges and opportunities. In: Corr PJ, editor. Cambridge: Cambridge University Press; 2008. pp. 120–54.
    Christensen MV, Kessing LV. Do personality traits predict first onset in depressive and bipolar disorder? Nord J Psychiatry. 2006;60:7988. [DOI] [PubMed]
    Barnett JH, Huang J, Perlis RH, Young MM, Rosenbaum JF, Nierenberg AA, et al. Personality and bipolar disorder: dissecting state and trait associations between mood and personality. Psychol Med. 2011;41:1593604. [DOI] [PubMed] [PMC]
    Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord. 2003;73:12331. [DOI] [PubMed]
    Hoertel N, de Maricourt P, Gorwood P. Novel routes to bipolar disorder drug discovery. Expert Opin Drug Discov. 2013;8:90718. [DOI] [PubMed]
    Van Dijk S, Jeffrey J, Katz MR. A randomized, controlled, pilot study of dialectical behavior therapy skills in a psychoeducational group for individuals with bipolar disorder. J Affect Disord. 2013;145:38693. [DOI] [PubMed]
    Gitlin M. Treatment-resistant bipolar disorder. Mol Psychiatry. 2006;11:22740. [DOI] [PubMed]
    Zaretsky AE, Rizvi S, Parikh SV. How well do psychosocial interventions work in bipolar disorder? Can J Psychiatry. 2007;52:1421. [DOI] [PubMed]
    Scott J. Cognitive therapy as an adjunct to medication in bipolar disorder. Br J Psychiatry. 2001;178:S1648. [PubMed]
    Hofmann SG, Asnaani A, Vonk IJ, Sawyer AT, Fang A. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognit Ther Res. 2012;36:42740. [DOI] [PubMed] [PMC]
    Nielssen O, Staples L, Karin E, Kayrouz R, Dear B, Titov N. Effectiveness of internet delivered cognitive behaviour therapy provided as routine care for people in the depressed phase of bipolar disorder treated with lithium. PLOS Digit Health. 2023;2:e0000194. [DOI] [PubMed] [PMC]
    Henken HT, Kupka RW, Draisma S, Lobbestael J, van den Berg K, Demacker SMA, et al. A cognitive behavioural group therapy for bipolar disorder using daily mood monitoring. Behav Cogn Psychother. 2020;48:51529. [DOI] [PubMed]
    Weinstein SM, Henry DB, Katz AC, Peters AT, West AE. Treatment moderators of child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2015;54:11625. [DOI] [PubMed] [PMC]
    Steinan MK, Krane-Gartiser K, Langsrud K, Sand T, Kallestad H, Morken G. Cognitive behavioral therapy for insomnia in euthymic bipolar disorder: study protocol for a randomized controlled trial. Trials. 2014;15:24. [DOI] [PubMed] [PMC]
    West AE, Weinstein SM, Peters AT, Katz AC, Henry DB, Cruz RA, et al. Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: a randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2014;53:116878.e1. [DOI] [PubMed] [PMC]
    Costa RT, Cheniaux E, Rangé BP, Versiani M, Nardi AE. Group cognitive behavior therapy for bipolar disorder can improve the quality of life. Braz J Med Biol Res. 2012;45:8628. [DOI] [PubMed] [PMC]
    González-Isasi A, Echeburúa E, Limiñana JM, González-Pinto A. Predictors of good outcome in patients with refractory bipolar disorder after a drug or a drug and cognitive-behavioral treatment. Compr Psychiatry. 2012;53:2249. [DOI] [PubMed]
    Parikh SV, Scott J. Cognitive-behavioural therapy for bipolar disorder. In: Yatham LN, Maj M, editors. Bipolar disorder: clinical and neurobiological foundations. WILEY-BLACKWELL; 2010. pp. 422–9.
    Gomes BC, Abreu LN, Brietzke E, Caetano SC, Kleinman A, Nery FG, et al. A randomized controlled trial of cognitive behavioral group therapy for bipolar disorder. Psychother Psychosom. 2011;80:14450. [DOI] [PubMed]
    da Costa RT, Rangé BP, Malagris LE, Sardinha A, de Carvalho MR, Nardi AE. Cognitive-behavioral therapy for bipolar disorder. Expert Rev Neurother. 2010;10:108999. [DOI] [PubMed]
    West AE, Jacobs RH, Westerholm R, Lee A, Carbray J, Heidenreich J, et al. Child and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: pilot study of group treatment format. J Can Acad Child Adolesc Psychiatry. 2009;18:23946. [PubMed] [PMC]
    Zaretsky A, Lancee W, Miller C, Harris A, Parikh SV. Is cognitive-behavioural therapy more effective than psychoeducation in bipolar disorder? Can J Psychiatry. 2008;53:4418. [DOI] [PubMed]
    Reilly-Harrington NA, Deckersbach T, Knauz R, Wu Y, Tran T, Eidelman P, et al. Cognitive behavioral therapy for rapid-cycling bipolar disorder: a pilot study. J Psychiatr Pract. 2007;13:2917. [DOI] [PubMed]
    Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, et al. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry. 2006;188:31320. [DOI] [PubMed]
    Feeny NC, Danielson CK, Schwartz L, Youngstrom EA, Findling RL. Cognitive-behavioral therapy for bipolar disorders in adolescents: a pilot study. Bipolar Disord. 2006;8:50815. [DOI] [PubMed]
    Pavuluri MN, Graczyk PA, Henry DB, Carbray JA, Heidenreich J, Miklowitz DJ. Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: development and preliminary results. J Am Acad Child Adolesc Psychiatry. 2004;43:52837. [DOI] [PubMed]
    Patelis-Siotis I, Young LT, Robb JC, Marriott M, Bieling PJ, Cox LC, et al. Group cognitive behavioral therapy for bipolar disorder: a feasibility and effectiveness study. J Affect Disord. 2001;65:14553. [DOI] [PubMed]
    McMahon K, Herr NR, Zerubavel N, Hoertel N, Neacsiu AD. Psychotherapeutic treatment of bipolar depression. Psychiatr Clin North Am. 2016;39:3556. [DOI] [PubMed]
    Swartz HA, Frank E, Frankel DR, Novick D, Houck P. Psychotherapy as monotherapy for the treatment of bipolar II depression: a proof of concept study. Bipolar Disord. 2009;11:8994. [DOI] [PubMed] [PMC]
    Steardo L Jr, Luciano M, Sampogna G, Zinno F, Saviano P, Staltari F, et al. Efficacy of the interpersonal and social rhythm therapy (IPSRT) in patients with bipolar disorder: results from a real-world, controlled trial. Ann Gen Psychiatry. 2020;19:15. Erratum in: Ann Gen Psychiatry. 2020;19:28. [DOI] [PubMed] [PMC]
    Frank E, Swartz HA, Kupfer DJ. Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry. 2000;48:593604. [DOI] [PubMed]
    Bouwkamp CG, de Kruiff ME, van Troost TM, Snippe D, Blom MJ, de Winter RF, et al. Interpersonal and social rhythm group therapy for patients with bipolar disorder. Int J Group Psychother. 2013;63:97115. [DOI] [PubMed]
    Hlastala SA, Kotler JS, McClellan JM, McCauley EA. Interpersonal and social rhythm therapy for adolescents with bipolar disorder: treatment development and results from an open trial. Depress Anxiety. 2010;27:45764. [DOI] [PubMed] [PMC]
    Frank E, Soreca I, Swartz HA, Fagiolini AM, Mallinger AG, Thase ME, et al. The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder. Am J Psychiatry. 2008;165:155965. [DOI] [PubMed] [PMC]
    Orhan M, Korten N, Mans N, van Schaik D, Kupka R, Stek M, et al. Feasibility and acceptability of group interpersonal and social rhythm therapy for recurrent mood disorders: a pilot study. Am J Psychother. 2023;[Epub ahead of print]. [DOI] [PubMed]
    Linehan MM, Heard HL, Armstrong HE. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Arch Gen Psychiatry. 1993;50:9714. [DOI] [PubMed]
    McKay M, Wood JC, Brantley J. The dialectical behavior therapy skills workbook: practical DBT exercises for learning mindfulness, interpersonal effectiveness, emotion regulation, and distress tolerance. New Harbinger Publications; 2007.
    Goldstein TR, Axelson DA, Birmaher B, Brent DA. Dialectical behavior therapy for adolescents with bipolar disorder: a 1-year open trial. J Am Acad Child Adolesc Psychiatry. 2007;46:82030. [DOI] [PubMed] [PMC]
    Samadi F, Bahrinian S, Razjoyan K, Shahabizadeh F. The effectiveness of dialectical behavior therapy on aggression, self-criticism and self-injurious behaviors of aged 12-18 year with bipolar disorder. RRJ. 2023;12:5566. Persian.
    Afshari B, Omidi A, Ahmadvand A. Effects of dialectical behavior therapy on executive functions, emotion regulation, and mindfulness in bipolar disorder. J Contemp Psychother. 2019;50:12331. [DOI]
    Eisner L, Eddie D, Harley R, Jacobo M, Nierenberg AA, Deckersbach T. Dialectical behavior therapy group skills training for bipolar disorder. Behav Ther. 2017;48:55766. [DOI] [PubMed] [PMC]
    Miklowitz DJ. Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry. 2008;165:140819. [DOI] [PubMed] [PMC]
    Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry. 2003;60:90412. [DOI] [PubMed]
    Tabas MY, Momeni F, Bakhshani NM, Pourshahbaz A, Rezaei O. Effectiveness of family-focused therapy in bipolar patients in Zahedan city, Iran: a randomized controlled trial. Iran J Psychiatry Behav Sci. 2023;[Epub ahead of print]. [DOI]
    Fredman SJ, Baucom DH, Boeding SE, Miklowitz DJ. Relatives’ emotional involvement moderates the effects of family therapy for bipolar disorder. J Consult Clin Psychol. 2015;83:8191. [DOI] [PubMed] [PMC]
    Miklowitz DJ, Chung B. Family-focused therapy for bipolar disorder: reflections on 30 years of research. Fam Process. 2016;55:48399. [DOI] [PubMed] [PMC]
    Solomon DA, Keitner GI, Ryan CE, Kelley J, Miller IW. Preventing recurrence of bipolar I mood episodes and hospitalizations: family psychotherapy plus pharmacotherapy versus pharmacotherapy alone. Bipolar Disord. 2008;10:798805. [DOI] [PubMed]
    Miller KB. Family-focused therapy program for bipolar disorder. Am Fam Physician. 2004;69:2668.
    Reinares M, Vieta E, Colom F, Martínez-Arán A, Torrent C, Comes M, et al. Impact of a psychoeducational family intervention on caregivers of stabilized bipolar patients. Psychother Psychosom. 2004;73:3129. [DOI] [PubMed]
    Weisman A, Tompson MC, Okazaki S, Gregory J, Goldstein MJ, Rea M, et al. Clinicians’ fidelity to a manual-based family treatment as a predictor of the one-year course of bipolar disorder. Fam Process. 2002;41:12331. [DOI] [PubMed]
    Segal ZV, Williams JMG, Teasdale JD. Mindfulness-based cognitive therapy for depression. The Guilford Press; 2013.
    Williams JM, Alatiq Y, Crane C, Barnhofer T, Fennell MJ, Duggan DS, et al. Mindfulness-based cognitive therapy (MBCT) in bipolar disorder: preliminary evaluation of immediate effects on between-episode functioning. J Affect Disord. 2008;107:2759. [DOI] [PubMed] [PMC]
    Deckersbach T, Hölzel BK, Eisner LR, Stange JP, Peckham AD, Dougherty DD, et al. Mindfulness-based cognitive therapy for nonremitted patients with bipolar disorder. CNS Neurosci Ther. 2012;18:13341. [DOI] [PubMed] [PMC]
    Miklowitz DJ, Alatiq Y, Goodwin GM, Geddes JR, Fennell MJV, Dimidjian S, et al. A pilot study of mindfulness-based cognitive therapy for bipolar disorder. Int J Cogn Ther. 2009;2:37382. [DOI]
    Perich T, Manicavasagar V, Mitchell PB, Ball JR, Hadzi-Pavlovic D. A randomized controlled trial of mindfulness-based cognitive therapy for bipolar disorder. Acta Psychiatr Scand. 2013;127:33343. [DOI] [PubMed]
    Deckersbach T, Hansen N, Holzel B. Chapter 4 - Mindfulness-based cognitive therapy for bipolar disorder. In: Baer RA, editor. Mindfulness-based treatment approaches. San Diego: Academic Press; 2014. pp. 77–94.
    Lovas DA, Schuman-Olivier Z. Mindfulness-based cognitive therapy for bipolar disorder: a systematic review. J Affect Disord. 2018;240:24761. [DOI] [PubMed] [PMC]
    Hanssen I, Scheepbouwer V, Huijbers M, Regeer E, Lochmann van Bennekom M, Kupka R, et al. Adverse or therapeutic? A mixed-methods study investigating adverse effects of mindfulness-based cognitive therapy in bipolar disorder. PLoS One. 2021;16:e0259167. [DOI] [PubMed] [PMC]
    Weber B, Sala L, Gex-Fabry M, Docteur A, Gorwood P, Cordera P, et al. Self-reported long-term benefits of mindfulness-based cognitive therapy in patients with bipolar disorder. J Altern Complement Med. 2017;23:53440. [DOI] [PubMed]
    Miklowitz DJ, Semple RJ, Hauser M, Elkun D, Weintraub MJ, Dimidjian S. Mindfulness-based cognitive therapy for perinatal women with depression or bipolar spectrum disorder. Cognit Ther Res. 2015;39:590600. [DOI] [PubMed] [PMC]
    Lahera G, Bayón C, Fe Bravo-Ortiz M, Rodríguez-Vega B, Barbeito S, Sáenz M, et al. Mindfulness-based cognitive therapy versus psychoeducational intervention in bipolar outpatients with sub-threshold depressive symptoms: a randomized controlled trial. BMC Psychiatry. 2014;14:215. [DOI] [PubMed] [PMC]
    Howells FM, Ives-Deliperi VL, Horn NR, Stein DJ. Mindfulness based cognitive therapy improves frontal control in bipolar disorder: a pilot EEG study. BMC Psychiatry. 2012;12:15. [DOI] [PubMed] [PMC]
    Stange JP, Eisner LR, Hölzel BK, Peckham AD, Dougherty DD, Rauch SL, et al. Mindfulness-based cognitive therapy for bipolar disorder: effects on cognitive functioning. J Psychiatr Pract. 2011;17:4109. [DOI] [PubMed] [PMC]
    Weber B, Jermann F, Gex-Fabry M, Nallet A, Bondolfi G, Aubry JM. Mindfulness-based cognitive therapy for bipolar disorder: a feasibility trial. Eur Psychiatry. 2010;25:3347. [DOI] [PubMed]